Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea

被引:3
|
作者
Liu, Jing [1 ]
Peng, Rui [1 ]
Tan, Qian [1 ]
Li, Bocun [1 ]
Chen, Jianyi [1 ]
Liu, Guangya [1 ]
Wang, Yawen [1 ]
Li, Chao [1 ]
Li, Jia [1 ]
Wang, Hua [1 ]
机构
[1] Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China
来源
PLOS ONE | 2022年 / 17卷 / 09期
关键词
SMALL-INTESTINE; STRESS; ELECTROACUPUNCTURE; DIAGNOSIS; IDENTIFICATION; STIMULATION; PREDOMINANT; MECHANISMS; GENE; IBS;
D O I
10.1371/journal.pone.0273853
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To investigate the molecular pathological mechanisms of irritable bowel syndrome with diarrhea (IBS-D) and elucidate the effects of acupuncture on IBS-D colonic mucosa protein abundance in rats, a label-free high-throughput liquid chromatography-tandem mass spectrometry (LC-MS)-based proteomics analysis was used to survey the global changes of colonic mucosa proteins between different groups. Sixteen Sprague-Dawley (SD) male rats were randomly divided into four groups: the control group (C); the IBS-D model group (M); the syndrome differentiation acupuncture group (SD) and the traditional acupuncture group (T). IBS-D model rats were obtained using the CAS (chronic acute combining stress model) method. Comparative bioinformatics analysis of the proteomic data was analyzed using MaxQuant software, Perseus software, online tools DAVID, VENNY and STRING. Functional enrichment and network analyses revealed a close relationship between IBS-D and several biological processes including energy metabolism, muscular excitation/contraction, and both traditional acupuncture and syndrome differentiation acupuncture can reverse the impairments of normal energy metabolism. Moreover, the syndrome differentiation acupuncture can regulate the protein cluster relating inflammation, wound repair and cell protection against oxidative stress which is associated with acupuncture analgesic effect. Differentially expressed proteins Atp5a1 and Bpnt1 were selected as representative proteins and subjected to western blotting. In conclusion, our study provides further insight into the pathological and molecular mechanisms of IBS-D and acupuncture treatments, and serves as an experimental basis for clinical applications.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Sobolewska-Wlodarczyk, Aleksandra
    Wlodarczyk, Marcin
    Storr, Martin
    Fichna, Jakub
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 771 - 775
  • [22] Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
    Liu, Rebecca
    Staller, Kyle
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1391 - 1400
  • [23] Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline
    Gawron, Andrew J.
    Bielefeldt, Klaus
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 378 - +
  • [24] Changes in Enteric Neurons of Small Intestine in a Rat Model of Irritable Bowel Syndrome with Diarrhea
    Li, Shan
    Fei, Guijun
    Fang, Xiucai
    Yang, Xilin
    Sun, Xiaohong
    Dian, Jiaming
    Wood, Jackie D.
    Ke, Meiyun
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (02) : 310 - 320
  • [25] Management of irritable bowel syndrome with diarrhea: focus on eluxadoline
    Jones, Jennifer
    Lembo, Anthony
    Heidelbaugh, Joel
    Kuritzky, Louis
    Lacy, Brian
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 567 - 578
  • [26] Irisin prevents visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome
    Nozu, Tsukasa
    Miyagishi, Saori
    Ishioh, Masatomo
    Takakusaki, Kaoru
    Okumura, Toshikatsu
    PEPTIDES, 2025, 188
  • [27] Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome
    Nozu, Tsukasa
    Miyagishi, Saori
    Ishioh, Masatomo
    Takakusaki, Kaoru
    Okumura, Toshikatsu
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [28] Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
    Porter, Chad K.
    Cash, Brooks D.
    Pimentel, Mark
    Akinseye, Akintunde
    Riddle, Mark S.
    BMC GASTROENTEROLOGY, 2012, 12
  • [29] Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome
    Wu, Bi-Yu
    Xu, Ping
    Cheng, Li
    Wang, Qian-Qian
    Qiu, Hong-Yi
    Yan, Xiu-Juan
    Chen, Sheng-Liang
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (02)
  • [30] Microinflammation in the intestinal mucosa and symptoms of irritable bowel syndrome
    Yoshimoto, Takanori
    Oshima, Tadayuki
    Huang, Xinyi
    Tomita, Toshihiko
    Fukui, Hirokazu
    Miwa, Hiroto
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (02) : 62 - 69